Literature DB >> 9634769

Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins.

E Koivunen1, B Wang, E Ruoslahti.   

Abstract

We have isolated selective ligands to the cell surface receptors of fibronectin (alpha 5 beta 1 integrin), vitronectin (alpha v beta 3 and alpha v beta 5 integrins) and fibrinogen (alpha IIb beta 3 integrin) from phage libraries expressing cyclic peptides. A mixture of libraries was used that express a series of peptides flanked by a cysteine residue on each side (CX5C, CX6C, CX7C) or only on one side (CX9) of the insert. A majority of the integrin-binding sequences derived from the CX9 library contained another cysteine, indicating preferential selection of conformationally constrained cyclic peptides. Each of the four integrins studied primarily selected RGD-containing phage sequences but favored different ring sizes and different flanking residues around the RGD motif. A cyclic peptide ACRGDGWCG was synthesized based on a phage sequence that bound particularly avidly to the alpha 5 beta 1 integrin. This peptide inhibited cell attachment to fibronectin at about 5-fold lower concentrations than the most potent cyclic peptides described earlier. The most interesting structure appeared to contain two disulphide bonds. One such peptide, ACDCRGDCFCG, was synthetized and shown to be at least 20-fold more potent inhibitor of alpha v beta 5- and alpha v beta 3-mediated cell attachment to vitronectin than similar peptides with a single disulphide bond and 200-fold more potent than commonly used linear RGD peptides. These results emphasize the importance of conformational restriction as a means of improving the potency of integrin-binding peptides and point to a new way of designing effective peptides by resticting the peptide conformation with more than one cyclizing bond.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9634769     DOI: 10.1038/nbt0395-265

Source DB:  PubMed          Journal:  Biotechnology (N Y)        ISSN: 0733-222X


  118 in total

1.  Crystal structure of a heparin- and integrin-binding segment of human fibronectin.

Authors:  A Sharma; J A Askari; M J Humphries; E Y Jones; D I Stuart
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

2.  Heteroduplex mobility assay (HMA) pre-screening: an improved strategy for the rapid identification of inserts selected from phage-displayed peptide libraries.

Authors:  F Fack; S Deroo; S Kreis; C P Muller
Journal:  Mol Divers       Date:  2000       Impact factor: 2.943

3.  The rational design of a 'type 88' genetically stable peptide display vector in the filamentous bacteriophage fd.

Authors:  D Enshell-Seijffers; L Smelyanski; J M Gershoni
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

Review 4.  Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials.

Authors:  Jaesung Kim; Pyung-Hwan Kim; Sung Wan Kim; Chae-Ok Yun
Journal:  Biomaterials       Date:  2011-12-03       Impact factor: 12.479

5.  Integrin alpha3beta1 is an alternative cellular receptor for adenovirus serotype 5.

Authors:  Barbara Salone; Yuri Martina; Stefania Piersanti; Enrico Cundari; Gioia Cherubini; Laure Franqueville; Cristina M Failla; Pierre Boulanger; Isabella Saggio
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 6.  Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.

Authors:  Xiao-Xiang Zhang; Henry S Eden; Xiaoyuan Chen
Journal:  J Control Release       Date:  2011-10-26       Impact factor: 9.776

7.  Integrin-targeting block copolymer probes for two-photon fluorescence bioimaging.

Authors:  Sanchita Biswas; Xuhua Wang; Alma R Morales; Hyo-Yang Ahn; Kevin D Belfield
Journal:  Biomacromolecules       Date:  2010-12-29       Impact factor: 6.988

8.  Tropism modification of adenovirus vectors by peptide ligand insertion into various positions of the adenovirus serotype 41 short-fiber knob domain.

Authors:  Andrea Hesse; Daniela Kosmides; Roland E Kontermann; Dirk M Nettelbeck
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

Review 9.  Issues related to targeted delivery of proteins and peptides.

Authors:  Yingjuan Lu; Jun Yang; Emanuela Sega
Journal:  AAPS J       Date:  2006-07-21       Impact factor: 4.009

10.  Tissue-penetrating delivery of compounds and nanoparticles into tumors.

Authors:  Kazuki N Sugahara; Tambet Teesalu; Priya Prakash Karmali; Venkata Ramana Kotamraju; Lilach Agemy; Olivier M Girard; Douglas Hanahan; Robert F Mattrey; Erkki Ruoslahti
Journal:  Cancer Cell       Date:  2009-12-08       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.